Novidin (Hydroxychloroquine Sulfate)

Hydroxychloroquine Sulfate, the active ingredient in Novidin, is an antimalarial presented as a tablet for oral use. It belongs to the disease-modifying antirheumatic drug (DMARD) class and exhibits immunomodulatory properties. The drug is used to prevent and treat malaria and to manage rheumatoid arthritis and systemic lupus erythematosus.

GNH USA supplies Novidin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory support for import and distribution, offering reliable batch consistency, comprehensive documentation, and responsive technical assistance.

Hydroxychloroquine Sulfate is an antimalarial and immunomodulatory agent used across several disease categories.

- Malaria prophylaxis: prevents infection in travelers and residents of endemic areas. - Malaria treatment: clears blood‑stage parasites and resolves acute infection. - Rheumatoid arthritis: reduces joint inflammation and slows disease progression. - Systemic lupus erythematosus: controls disease activity and reduces flare frequency.

Hydroxychloroquine Sulfate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: occasional stomach upset. - Diarrhea: loose stools, usually transient. - Skin rash: mild erythematous eruptions.

Serious or Rare Side Effects: - Retinal toxicity: can lead to irreversible vision loss. - Cardiac arrhythmias: QT interval prolongation may cause serious rhythm disturbances. - Hemolytic anemia in G6PD deficiency: risk of red blood cell breakdown.

When prescribing Hydroxychloroquine Sulfate, clinicians should consider several safety measures.

- Pregnancy: Category B; use only if benefits outweigh potential risks. - Renal impairment: monitor kidney function and adjust dose if necessary. - Retinal screening: obtain baseline ophthalmologic exam and repeat annually. - Cardiac monitoring: perform ECG in patients with known cardiac disease. - Drug interactions: avoid concomitant use with other QT‑prolonging agents. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Hydroxychloroquine Sulfate interacts with several medicines; awareness of the interaction level guides clinical decisions.

Major Interactions (Avoid): - QT‑prolonging drugs (e.g., quinidine, azithromycin): may precipitate serious arrhythmias. - Strong CYP2D6 inhibitors (e.g., fluoxetine): increase hydroxychloroquine plasma concentrations. - Insulin or oral hypoglycemics: can cause severe hypoglycemia.

Moderate Interactions (Monitor Closely): - Antacids: may reduce absorption; separate dosing by at least 2 hours. - Methotrexate: potential increase in toxicity; monitor blood counts. - Other immunosuppressants: enhanced immunosuppression; watch for infection signs.